NCT02935855View on ClinicalTrials.gov

ORal anticoaGulants in diAbetic and Nondiabetic Patients With nOn-valvular Atrial fibrillatioN (ORGANON)

PHASE4CompletedINTERVENTIONAL

Enrollment

300

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

April 30, 2019

Study Completion Date

September 30, 2019

Conditions

Diabetes

Interventions

DRUG

Dabigatran

DRUG

Apixaban

DRUG

Rivaroxaban

DRUG

Edoxaban

DRUG

Warfarin

DRUG

Acenocumarole

Trial Locations (1)

27100

IRCCS Policlinico San Matteo, Pavia

All Listed Sponsors

lead

University of Pavia

OTHER

NCT02935855 - ORal anticoaGulants in diAbetic and Nondiabetic Patients With nOn-valvular Atrial fibrillatioN (ORGANON) | Biotech Hunter | Biotech Hunter